Anybody playing TELK? Looks like they will be releasing 3 Phase 3 trial data before the end of this year for Ovarian cancer, lung cancer and blood disorder. The upside/downside could be huge here. Anybody have informed opinion of which way the trial will go? TIA. Btw, the near term option premiums are naturally very pricey.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.